These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35240725)
1. The impact of fetal growth restriction in diagnosing preeclampsia on the severity of maternal features. Kasuya M; Akiba N; Iriyama T; Sayama S; Kubota K; Toshimitsu M; Seyama T; Sone K; Kumasawa K; Nagamatsu T; Fujii T; Osuga Y J Obstet Gynaecol Res; 2022 Apr; 48(4):912-919. PubMed ID: 35240725 [TBL] [Abstract][Full Text] [Related]
2. Fetal growth restriction as a diagnostic criterion for preeclampsia. Obata S; Toda M; Tochio A; Hoshino A; Miyagi E; Aoki S Pregnancy Hypertens; 2020 Jul; 21():58-62. PubMed ID: 32413588 [TBL] [Abstract][Full Text] [Related]
3. Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension. Zheng W; Zhang X; Feng Y; Liu B; Zhu J; Zou Y; Qin J; Li B JAMA Netw Open; 2022 Aug; 5(8):e2226696. PubMed ID: 35969398 [TBL] [Abstract][Full Text] [Related]
4. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study. Reddy M; Fenn S; Rolnik DL; Mol BW; da Silva Costa F; Wallace EM; Palmer KR Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430 [TBL] [Abstract][Full Text] [Related]
5. Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study. Takahashi M; Makino S; Oguma K; Imai H; Takamizu A; Koizumi A; Yoshida K BMC Pregnancy Childbirth; 2021 Oct; 21(1):678. PubMed ID: 34615491 [TBL] [Abstract][Full Text] [Related]
6. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study. Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169 [TBL] [Abstract][Full Text] [Related]
7. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study. Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of fetal growth restriction complicated later by preeclampsia. Mitani M; Matsuda Y; Makino Y; Akizawa Y; Ohta H J Obstet Gynaecol Res; 2009 Oct; 35(5):882-7. PubMed ID: 20149036 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia. Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492 [TBL] [Abstract][Full Text] [Related]
12. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia. McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794 [TBL] [Abstract][Full Text] [Related]
13. OS078. Fetal growth restriction: A marker of severity of early-onset pre-eclampsia? Khalil A; Suff N; Grande A; David A; Khalil A Pregnancy Hypertens; 2012 Jul; 2(3):220. PubMed ID: 26105292 [TBL] [Abstract][Full Text] [Related]
14. Maternal subclinical vascular changes in fetal growth restriction with and without pre-eclampsia. Stergiotou I; Bijnens B; Cruz-Lemini M; Figueras F; Gratacos E; Crispi F Ultrasound Obstet Gynecol; 2015 Dec; 46(6):706-12. PubMed ID: 25678131 [TBL] [Abstract][Full Text] [Related]
16. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat. Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512 [TBL] [Abstract][Full Text] [Related]
17. Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction. Youssef L; Simões RV; Miranda J; García-Martín ML; Paules C; Crovetto F; Amigó N; Cañellas N; Gratacos E; Crispi F Sci Rep; 2021 Jul; 11(1):14422. PubMed ID: 34257400 [TBL] [Abstract][Full Text] [Related]
18. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction. Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598 [TBL] [Abstract][Full Text] [Related]
19. Severe early-onset PE with or without FGR in Chinese women. Shen H; Zhao X; Li J; Chen Y; Liu Y; Wang Y; Liu X; Cheng W Placenta; 2020 Nov; 101():108-114. PubMed ID: 32949793 [TBL] [Abstract][Full Text] [Related]
20. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Kovo M; Schreiber L; Ben-Haroush A; Gold E; Golan A; Bar J Prenat Diagn; 2012 Jul; 32(7):632-7. PubMed ID: 22565848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]